We are live on ! Find out more
ALBO

Albireo Pharma Inc
ALBO

Delisted

ALBO was delisted on the 2nd of March, 2023.

Back to rankings

67 hedge funds and large institutions have $256M invested in Albireo Pharma Inc in 2018 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 26 increasing their positions, 18 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

44% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 18

3% less funds holding

Funds holding: 69 → 67 (-2)

5% less capital invested

Capital invested by funds: $270M → $256M (-$13.7M)

29% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 7

Holders
67
Holders Change
-2
Holders Change %
-2.9%
% of All Funds
1.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
26
Reduced
18
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PM
Prosight Management
Texas
+$5.33M
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$2.27M
3
BlackRock
BlackRock
New York
+$1.96M
4
ACH
ArrowMark Colorado Holdings
Colorado
+$1.4M
5
MWNA
Marshall Wace North America
New York
+$1.12M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$4.8M
2
Renaissance Technologies
Renaissance Technologies
New York
-$2.13M
3
Millennium Management
Millennium Management
New York
-$1.24M
4
Two Sigma Investments
Two Sigma Investments
New York
-$1.08M
5
EMG
Ellington Management Group
Connecticut
-$444K
Name Holding Trade Value Shares
Change 		Change in
Stake
BC
26
Birchview Capital
Vermont
$1.25M – – –
Bank of New York Mellon
27
Bank of New York Mellon
New York
$1.15M +$90.3K +2,760 +9%
MWNA
28
Marshall Wace North America
New York
$1.13M +$1.12M +34,271 New
SLG
29
Stanley-Laman Group
Pennsylvania
$1.08M +$1.07M +32,788 New
PPA
30
Parametric Portfolio Associates
Washington
$1M +$314K +9,599 +46%
Prudential Financial
31
Prudential Financial
New Jersey
$829K +$67.9K +2,075 +9%
AA
32
ALPS Advisors
Colorado
$698K +$128K +3,924 +23%
Deutsche Bank
33
Deutsche Bank
Germany
$680K -$73.9K -2,260 -10%
TA
34
Teachers Advisors
New York
$649K +$75.1K +2,297 +13%
Charles Schwab
35
Charles Schwab
California
$630K – – –
EP
36
Eversept Partners
New York
$594K – – –
TCIM
37
TIAA CREF Investment Management
New York
$590K -$270K -8,248 -32%
Morgan Stanley
38
Morgan Stanley
New York
$502K -$150K -4,589 -23%
UBS Group
39
UBS Group
Switzerland
$478K +$108K +3,287 +29%
VEA
40
Virtus ETF Advisers
New York
$469K -$342K -10,448 -42%
California State Teachers Retirement System (CalSTRS)
41
California State Teachers Retirement System (CalSTRS)
California
$462K +$3.01K +92 +0.7%
JMH
42
J.M. Hartwell
New York
$432K -$9.81K -300 -2%
New York State Common Retirement Fund
43
New York State Common Retirement Fund
New York
$336K – – –
AAP
44
Ardsley Advisory Partners
Connecticut
$333K -$164K -5,000 -33%
State of Wisconsin Investment Board
45
State of Wisconsin Investment Board
Wisconsin
$313K +$311K +9,500 New
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$307K -$4.09K -125 -1%
Acadian Asset Management
47
Acadian Asset Management
Massachusetts
$281K +$127K +3,868 +83%
AIG
48
American International Group
New York
$199K +$3.53K +108 +2%
MIM
49
MetLife Investment Management
New Jersey
$155K – – –
Wells Fargo
50
Wells Fargo
California
$154K +$116K +3,550 +315%
1
2
3

ALBO Hedge Fund Activity: Q3 2018 in Review

67 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q3 2018, worth a combined $256M — down 5.1% from $270M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of ALBO and 5 opened new positions — a net loss of 2 holders — while 18 trimmed existing stakes and 26 added.

The largest buyer was Prosight Management, opening a new position worth an estimated $5.33M. The largest seller was Fidelity Investments, cutting an estimated $4.8M.

  • 67 institutional investors held Albireo Pharma Inc (ALBO) as of Q3 2018, down from 69 in Q2 2018.
  • Funds reported $256M of Albireo Pharma Inc stock for Q3 2018, down 5.1% quarter-over-quarter.
  • 5 funds opened new Albireo Pharma Inc positions in Q3 2018 and 7 closed out, a net change of -2 holders.
  • The largest Albireo Pharma Inc buyer in Q3 2018 was Prosight Management, an estimated $5.33M added.
  • The largest Albireo Pharma Inc seller in Q3 2018 was Fidelity Investments, an estimated $4.8M sold.

Based on aggregated 13F filings for Q3 2018.